Glioblastoma and New Therapeutic Drugs and Approaches

Glioblastoma is the most aggressive and lethal form of primary brain tumor in adults, characterized by rapid growth, high invasiveness, and resistance to conventional therapies. Current treatment options offer limited survival benefits. However, recent advancements in molecular biology, genomics, and drug delivery systems pave the way for more effective, targeted therapeutic strategies. Emerging approaches include immunotherapy, gene editing, and personalized medicine. Novel drug candidates and repurposed agents are explored in clinical trials, overcoming the blood-brain barrier and targeting specific mutations driving glioblastoma progression. These evolving therapies may improve outcomes and transform the future landscape of glioblastoma treatment. Glioblastoma and New Therapeutic Drugs and Approaches explores glioblastoma and new therapeutic drugs under development. It examines innovative treatment modalities, drug delivery regimens, and therapeutic strategies to address glioblastoma care. This book covers topics such as nanomaterials, chemistry, and medical diagnosis, and is a useful resource for medical and healthcare professionals, engineers, drug developers, oncologists, academicians, researchers, and scientists.